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ABSTRACT 
 
The retinoblastoma protein (Rb) is a transcription regulator and key component of the 
Rb/E2F/DP pathway which regulates progression of the cell cycle in plants and animals. 
Within the pathway, Rb blocks E2F transcriptional activity consequently ensuring 
restricted cell proliferation. Of great importance too, is a family of posttranslational 
modifiers referred to as small ubiquitin-related modifiers (SUMO), whose modification 
consequences include; sub cellular localization of proteins, alteration of protein to protein 
interaction and regulation of transcriptional activity. 
 
In order to study and depict the plant retinoblastoma related protein (RBR1) as a SUMO 
substrate; its modification site was mutated to address the effect of the mutation on 
protein localization. Additionally, an in-vitro assay was used to further illustrate the 
consequences of the mutation. In protoplasts transfected with wild type RBR1 the protein 
was solely present in the nucleus while those transfected with mutated RBR1, the protein 
was seen in both the nucleus and the cytosol. From the in vitro SUMOylation assay it was 
evident that while wild type RBR1 could be modified by SUMO, its mutated version 
could not undergo modification. 

The results from this study don’t only show RBR1 as a SUMO substrate; they also 
suggest that modification by SUMO could be needed for its sub-cellular localization. 



CHAPTER ONE 
INTRODUCTION 
1.0 Background 
The growth, development and division of cells within multi-cellular organisms such as 
plants depends on a sequence of synchronized events which are spatially and temporarily 
tightly regulated within individual cells (Desvoyes et al., 2006). Furthermore, organ 
development in plants is just about a post embryonic process; as a result organogenesis 
depends on constant ability of a given set of cells to grow prior to undergoing specific 
differentiation programs (Desvoyes et al., 2006). Consequently the post-embryonic 
nature of organogenesis, multi-cellularity of plants requires precise linking of cell 
proliferation, differentiation and arrest of the cell cycle so that all processes are 
coordinated with the overall development program (Desvoyes et al., 2006). 
 
Unlike animals, development of new plant organs such as roots, leaves and flowers 
repeatedly occurs over the plants life span which can at times extend over thousands of 
years. As a result of continuous organogenesis, regulation of the cell cycle is of 
fundamental importance for plant growth and development (Wildwater et al. 2005; Inze 
et al., 2006). 
 Gutierrez and co workers (2002) acknowledged that in addition to hormonal signals, a 
key regulator of the plant cell cycle is the Rb/E2F/DP pathway which consists of the 
retinoblastoma protein (Rb) and the E2F transcription factor. Rb functions by binding the 
E2F transcription factor consequently blocking transcription of cell related cycle genes; 
this in turn prevents uncontrolled proliferation of cells (Brehm et al., 1999).  


Like most proteins, Rb is subject to posttranslational modification by processes such as 
phosphorylation, glucosylation and acetylation resulting in chemical alteration of the 
amino acids within the protein (Verger et al., 2003). Alternatively the protein can also be 
modified by addition of other polypeptides such as ubiquitin and the small ubiquitin 
related modifiers also referred to as SUMO (Verger et al., 2003; Gill, 2004). The 
consequences of these modifications include sub-cellular localization of proteins, 
alteration of protein to protein interactions and degradation of proteins (Richards, 2008). 
1.1 Objectives of the study 
Conjugation of SUMO to substrate proteins has been implicated in regulation of a 
number of cellular processes ranging from nuclear transport, cell cycle control; 
transcription regulation and DNA repair (Gill, 2004). Earlier in-vitro experimentation in 
the Bako lab (UPSC) had shown that the plant retinoblastoma-related protein RBR1, 
whose function is crucial for plant cell division and development, is modified by SUMO. 
The site(s) of modification and functional consequence of SUMOylation on RBR1 
function were however yet to be determined. Hence the objectives of this study were; 
1. To indentify a site(s) on Arabidopsis RBR1 protein modified by SUMO followed 
by; PCR-directed mutagenesis of predicted conjugation site(s), as well as analysis 
of mutant proteins by in vitro SUMOylation assays. 
       2. Functional studies of RBR1 carrying mutation(s) of SUMO conjugation site(s)      
through; Transient expression of RBR1 mutant fused to GFP in plant cells to 
investigate the effect of mutation on intracellular localization using confocal 
microscopy. 
 

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CHAPTER TWO 
LITERATURE REVIEW 
2.1      The Plant Cell-cycle 
The cell cycle also referred to as the cell-division cycle involves a sequence of four 
coordinated events culminating in replication of the cells genetic material. The four 
events include; Gap phases (G1 and G2) which separate DNA replication (S phase) and 
the M (mitosis) phase respectively (Ferreira et al., 1994). An additional role of gap 
phases within the cycle is to serve as check points’ ensuring each phase is successfully 
completed before the next is initiated (Ferreira et al., 1994; Dewitte et al., 2003).  
Under the influence of hormonal signals and metabolic changes during G1 Phase, cells 
start preparing for the impending division (Dewitte et al., 2003). At a certain point, the 
cell moves into S-phase during which genetic material is replicated and doubled resulting 
in chromosomes with two sister chromatids. The cell subsequently moves into G2
 
phase 
during which it continues to grow while assembling cytoplasmic material required for 
eventual division. The final phase of the cycle is M phase which involves nuclear 
division accompanied by cytoplasmic division (cytokinesis) resulting into two daughter 
cells (Dewitte et al., 2003). 
2.2       Regulation of the cell cycle 
2.2.1     Cyclins and cyclin dependent Kinases (CDKs) 

Regulation of the cell cycle is essential to ensure; division of cells never occurs until all 
DNA has been replicated and repaired in case of damages (Inze et al., 2006). Hence cycle 
regulation occurs throughout the cell division machinery with a unique characteristic of 


all regulation points being under the control of cyclin dependent kinases (CDKs) (Pines, 
1999). 
Cyclins are a multi group of proteins characterized by a poorly conserved region essential 
for interaction with partner CDKs. The conserved cyclin region is 250 amino acids long 
comprising of two folds of five helices (Dewitte et al., 2003). Using sequence based 
classification; five types of cyclins (A, B, C, D and H) have been indentified in plants 
with significant roles at different stages of the cell cycle (Renaudin et al., 1996; 
Vandepoele et al., 2002). “A-type cyclins appear at the beginning of the S-phase and play 
a role in its progression, B-type cyclins are involved in G2
 
/M transition while D-type 
cyclins control progression through G1 and S phase” (Dewitte et al., 2003). 
 
Pines (1999), noted that progression of the cell cycle is dependent on activation and 
deactivation of cyclin dependent kinases (CDKs) which belong to a conserved 
serine/theorine protein kinase family. CDKs remain inactive until their partner cyclins 
bind them to form Cyc-CDK complexes; these are then activated by CDK-activating 
kinases (CAKs) by phosphorylating threonine residues contained in CDK T-loops (Pines, 
1999). Consequently, CDK induced phosphorylation is responsible for onset of DNA 
replication and mitosis during S and M phases respectively (Pines, 1999; Inze et al., 
2006).  
Four CDKs namely CDKA1, CDKA2 and CDKB1, CDKB2 have been indentified in 
Arabidopsis thaliana belonging to CDKA and CDKB families respectively. CDK related 
studies in Antirrhinum cells revealed that CDKA activity is up regulated during G1
 
and S 


phase while CDKB activity is intense during S, G2 and M phases (Fobert et al., 1994; 
Joubes et al., 2000; Vandepoele et al 2002).  
Once activated, Cyc-CDKs covalently add phosphate groups to serine or threonine 
residues within substrate proteins consequently altering their properties. One notable 
substrate of CDKs is the retinoblastoma protein (Rb) whose phosphorylation is essential 
for progression of the cell cycle (Dewitte et al., 2003). 
2.2.2    Rb/E2F/DP Pathway 
The Rb/E2F/DP pathway controls transition from G1 to S phase of the plant cell cycle, it 
consists of the retinoblastoma protein (Rb) a transcription regulator and the E2F 
transcription factor (Gutierrez et al., 2002; Inze et al., 2006). According to Weinberg 
(1995), involvement of the Rb protein in regulation of cell division was originally 
exclusively associated with animals. However this view changed as a result of the 
discovery that Rb related proteins and components of the Rb/E2F/DP pathway do 
actually exist in plants too (Huntley et al., 1998) 
De Jager et al., (1999) referred to the Rb protein “as being part of a conserved pathway 
controlling the activation of cell division in animals”. It contains a number of functional 
domains two of which denoted A and B are conserved in humans and plants (Harbour et 
al., 2000). Furthermore, interaction of the two domains results in formation of a central 
pocket which enables Rb to interact with partner proteins such as cyclin D, histone 
deacetylases via their LxCxE motifs (L-leucine, C-cysteine, E-glutamic acid and x being 
any amino acid) (Harbour, 1998).  
Rb is a nuclear protein characterized by a number of potential binding sites for CDKs.  
Furthermore, the protein is crucial in regulation of the cell cycle, cell differentiation 


during which it functions by blocking E2F transcription activity consequently preventing 
uncontrolled cell proliferation (Dewitte et al., 2003). The importance of Rb in cell cycle 
regulation was elucidated by inhibiting its function through virus-induced gene silencing 
which resulted in prolonged cell proliferation and delayed differentiation of Nicotiana 
benthamiana leaf and stem cells (Park et al., 2005). Additionally, the plants showed 
retarded flower formation highlighting a possible role for Rb in flower development 
(Park et al., 2005). 
The second component of the cell cycle regulating pathway is a family of transcription 
factors referred to as E2Fs. E2Fs contain a DP heterodimerization domain enabling them 
to combine with DP proteins resulting in an active E2F/DP transcription complex which 
induces expression of genes involved in cell cycle progression (Desvoyes et al., 2006). 
Furthermore, E2Fs also contain binding domains to which the Rb protein binds to block 
transcription activity. Six E2Fs (E2Fa, E2Fb, E2Fc, DEL1, DEL2, and DEL3), two DP 
proteins (DPa and DPb) and a single Rb homolog (RBR1) have been indentified in 
Arabidopsis thaliana (Desvoyes et al., 2006; Hirano et al., 2008). 
2.2.2.1      Regulation of the Rb/E2F/DP Pathway 
Rb functions by binding E2F transcription factors (Figure 1A) consequently blocking 
transcription of cell cycle related genes (Brehm et al., 1999). Repression of E2F activity 
is due to the Retinoblastoma protein recruiting histone deacetylase (HDAC) enzymes 
which are co-repressors of transcription. HDACs remove acetyl groups from histones 
within DNA resulting in chromatin modification, condensation of DNA and inhibition of 
transcription (Brehm et al., 1999).  



Figure 1 Transition from G1 to S phase of the cell cycle in plants. (A) The 
retinoblastoma protein binds to the E2F/DP transcription factor blocking expression of 
cell cycle related genes. (B) Expression of D type cyclins in response to metabolite and 
hormonal signals leads to activation of cyclin dependent kinases. Activated CDKs go on 
to phosphorylated Rb, once Phosphorylated Rb activity is terminated leading to 
progression of the cell cycle (Modified from De Jager et al., 1999). 
 
However, in response to signals induced by metabolites (sucrose) and hormones (auxin 
and cytokinins), D-type cyclins are expressed (Figure 1B). CycDs subsequently bind their 
partner CDKs forming CycD-CDK complexes which are activated by CDK-activating 
kinases (CAKs). Active Cyc-CDKs are capeable of phosphorylating target proteins 
resulting in altered protein properties (Dewitte et al., 2003).  
The Retinoblastoma protein being a CDK target is phosphorylated leading to termination 
of its repression activity on the E2F transcription factor (De Jager et al., 1999). In 
absence of Rb induced repression (Figure 1B), E2Fs are eventually capeable of inducing 
the expression of genes involved in G1/S transition of the cell cycle (De Jager et al., 
1999; Dewitte et al., 2003).  
	

Xie and co workers (1995) reported that interaction between viral proteins and Rb 
induces direct entry of the cell cycle into the S phase. This is attributed to ability of viral 
proteins to mutate the LxCxE motif on the HDACs terminating their co-repression 
activity (Park et al., 2005). 
2.3     Posttranslational modification of proteins 
Posttranslational modification (PTM) is the chemical alteration of proteins after 
biosynthesis; it may involve a change in the chemical nature of amino acids through 
processes such as phosphorylation, acetylation, hydroxylation, glycosylation, alkylation 
and methylation. Alternatively, proteins can also be modified by addition of other 
polypeptides (Verger et al., 2003; Gill, 2004). The consequences of these modifications 
include localization and degradation of proteins (Richards, 2008). 
The most common polypeptide involved in PTM is the 76 amino acid (Ubiquitin) present 
in most eukaryotic species whose biological function is marking proteins for eventual 
degradation by the 26S proteasome (Kurepa et al., 2002). It is covalently attached to 
lysine residues within substrate proteins via an isopeptide bond formed between the 
lysine residues and a poly ubiquitin chain (Kurepa et al., 2002). The ubiquitination 
pathway is ATP dependent and relies on an activating enzyme (E1), conjugating enzyme 
(E2) and a ligase (E3) which enable poly-ubiquitination of target proteins (Kurepa et al., 
2002). 
In an ATP dependent reaction, E1 activates the ubiquitin precursor via a thiol ester bond 
formed between a glycine in ubiquitin and the cysteine end in the E1 enzyme (Smalle et 
al., 2004). Activated ubiquitin is then transferred to E2 or ubiquitin conjugating enzyme, 
eventually, ubiquitin is conjugated on to target proteins via an isopeptide bond between 



the C-terminal glycine of ubiquitin and the lysine residue of the substrate protein with the 
help of an E3 ligase enzyme (Smalle et al., 2004).  
2.3.1 SUMO  
In addition to ubiquitin, families of ubiquitin like proteins (Ubls) have over the years 
been discovered and found to be involved in post translational of proteins in animals and 
plants. Key among Ubls is a family referred to as SUMO with functions spread across a 
variety of biological processes (Johnson, 2004).    
SUMO is an acronym for small ubiquitin-related modifier, a family of conserved proteins 
present in all eukaryotes. SUMOs are approximately 11 KDa in molecular weight, 25 
amino acids longer than ubiquitin but with a 20% sequence identity with ubiquitin 
(Johnson, 2004). Initial identification of SUMO was in 1997 after unearthing its 
conjugation to the GTPase activating protein RanGAP1, a protein involved in nuclear 
transport and the cell cycle in animals (Matunis et al., 1998; Verger et al., 2003; Marx, 
2005). As is the case with ubiquitination, SUMOylation also involves addition of SUMO 
to lysine residues within substrate proteins. “SUMO modifies a number of proteins which 
participate in diverse cellular processes such as; transcriptional regulation, nuclear 
transport, maintenance of genome integrity, and signal transduction” (Verger et al., 2003; 
Johnson, 2004; Bossis et al., 2006).  
Three SUMOs have so far been indentified in animals namely; SUMO-1, SUMO-2 and 
SUMO-3 while a total of 9 genes (SUM1 to SUM9) with strong resemblance to animal 
and fungal SUMOs have been identified in Arabidopsis thaliana (Kim et al., 2002; 
Novatchkova et al., 2004). Although referred to as ubiquitin like proteins, there are 
notable differences between SUMO and ubiquitin; for instance SUMO-1contains a long 

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and flexible N-terminal which is absent in ubiquitin (Bayer et al., 1998). Secondly, unlike 
ubiquitin, SUMO-1 lacks Lysine-48 hence its inability to form multiple SUMOylation 
chains as is the case with ubiquitin (Bayer et al., 1998).  
 
Additionally, while ubiquitination is associated with marking proteins for degradation, 
SUMOylation has been implicated in influencing protein to protein interactions, 
regulating protein stability and sub-cellular localization of substrate proteins (Bossis et 
al., 2006). In plants, animals SUMO modification occurs at all development stages and 
their respective tissues. This is made possible by Specific SUMO proteases which de-
conjugate SUMO precursor from substrate proteins making it available to be reused, 
although the long term fate of sumoylated proteins remains altered even after the 
modifier has been de-conjugated (Verger et al., 2003; Gill, 2004; Hay, 2005; Bossis et 
al., 2006). 
2.3.2     SUMO conjugation pathway 
SUMOylation (Figure 2) occurs in the nucleus and cytoplasm in a pathway relying on 
enzymes similar to those in ubiquitination but specific to SUMO. The pathway makes use 
of an activating enzyme (E1), conjugating enzyme (E2) and a ligase (E3) (Johnson, 
2004).  
2.3.2.1   SUMO activating enzyme E1 
The activating enzyme consists of two un-identical protein sub units which must combine 
to form an active heterodimer.  In Arabidopsis thaliana the enzyme is denoted SAE 
(SUMO activating enzyme) with two subunits SAE1a and SAE1b whose gene 


annotations are At4g24940 and At5g50580 respectively (Johnson et al., 1997; 
Novatchkova et al., 2004). 
2.3.2.2 SUMO conjugating enzyme E2 
Contrary to ubiqutination in which E3 ligases ensure substrate specificity, previous in 
vitro studies have highlighted the SUMO cojugating enzyme as being able to attach 
SUMO on to substrates without the E3 ligase (Rodriguez et al. 1999 and 2001). A single 
E2 enzyme exists in Arabidopsis thaliana denoted SCE or SUMO conjugating enzyme 
(Novatchkova et al., 2004). 
Melchior et al., (2003) and Johnson (2006) attributed SUMO specificity to a short precise 
sequence which the conjugating and ligase enzymes recognize in all substrate proteins. 
“The sequence denoted KXE or -Lys-X-Glu; where  is a large hydrophobic amino 
acid; K the lysine residue which is modified; X is any residue; and E/Glu is glutamic acid 
(Johnson, 2006).  
 
 
 


 
Figure 2 The SUMO conjugation pathway. SUMO precursor is cleaved by SUMO 
proteases to expose the glycine at its C-terminal end. Cleaved SUMO is then 
energetically activated by the E1-activating enzyme and transferred to the conjugating 
enzyme (E2). The final step of the pathway involves attaching SUMO on to the substrate 
protein in the presence of an E3 ligase (Modified from Marx, 2005). 
 
 
Prior to activation (Figure 2), the SUMO precussor is processed by SUMO-specific 
proteases (SENPs) to expose the glycine at its C-terminal end. Then, in an ATP 
dependent reaction a thioester bond is formed between the exposed glycine and the 
catalytic cysteine of the activating enzyme (E1). Next, activated SUMO is transferred to 
the cysteine end of the E2 cojugating enzyme. The final step involves attachment of 
SUMO to lysine residues on target proteins a reaction that is aided by SUMO-E3-ligases 
(Johnson, 2004; Gill, 2004; Bossis et al., 2006). 
2.4 Regulation of SUMO conjugation 
Reversibility of the SUMOylation pathway is ensured by SUMO-specific proteases or 
isopeptidases which remove SUMOs from modified proteins making it available for re-

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use as a precursor (Johnson, 2006). Though effects of SUMOylation have clearly been 
established, not much is known about how the pathway is regulated. However, Johnson 
(2004) suggested that regulation of the pathway could be occurring during conjugation or 
de-conjugation of SUMO leading to change in amount of modified proteins.  
 
Studies in animals have however revealed a role for Gam1 protein in regulating SUMO 
conjugation and de-conjugation (Bossis et al., 2006). Gam1 is a viral protein residing in 
CELO (Chicken embryo lethal orphan virus); it is involved in transcriptional activation of 
cellular and viral genes that inactivate HDACs (Boggio et al., 2005).  
In an earlier study, Boggio and co workers (2004) showed that Gam1 targets SUMO E1 
and E2 enzymes. Consistent with this finding, cellular expression of Gam1 resulted in 
decreased levels of SUMO conjugates, implying that the protein could be targeting the 
respective SUMO enzymes for proteasome degradation (Boggio et al., 2005). 
Furthermore, abiotic factors such as heat shock, osmotic and oxidative stress have also 
been implicated in regulating the SUMOylation pathway in animals (Bossis et al., 2006).  
2.5   Biological effects of SUMO 
Various nuclear proteins with roles related to transcriptional regulation, DNA repair and 
signaling have been identified as targets of post translational modification by SUMOs 
resulting in sub cellular localization of the proteins and alteration of protein-protein 
interaction (Gill, 2004). SUMOylation also affects processes including DNA repair, 
hormonal signaling and stress response. 

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2.5.1 Modulation of transcriptional activity 
The majority of proteins modified by SUMO include signaling proteins, enzymes and 
transcription factors or regulators (Johnson, 2004). SUMOylation of the latter proteins 
results in increased repression of transcription activity, an assertion supported by studies 
in which mutation of SUMO acceptor lysines resulted in increased transcription activity. 
Additionally over expression of de-conjugating enzymes has also shown increased 
transcription activity in the previously affected transcription factors (Gill, 2005). 
According to Johnson (2004), inhibition of transcription activity could be due to SUMO 
induced interactions with proteins that co-repress transcription. Furthermore, some 
transcription factors could require post translation modification by processes such as 
phosphorylation and ubiquitination. However SUMOs have the added ability of 
preventing such modifications by blocking lysine residues where they would normally 
occur (Johnson, 2005). 
2.5.2 Sub-cellular localization of proteins      
Studies involving the first indentified SUMO substrate protein RanGAP1 have revealed a 
role of SUMOylation in sub cellular localization of proteins. RanGAP1 is a GTPase 
activating protein with a significant role in protein transportation into the nucleus via the 
nuclear pore complex (Melchior et al., 1993; Gill, 2004). In animals unmodified 
RanGAP1 is located in the cytoplasm, however subsequent to SUMOylation the protein 
is present in the nuclear pore. Additionally, the modified protein shows increased 
interaction with the nuclear protein RANBP2 (RAN binding protein2) which could imply 
structural alterations within sumoylated RanGAP1 resulting in elevated levels of 
interaction with RANBP2 (Matunis et al., 1996). Consistent with this suggestion, protein 

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sequencing showed that interaction between RanGAP1 and RANBP2 required prior 
modification of RanGAP1 by SUMO (Matunis et al., 1996 and 1998) 
2.5.3 DNA repair 
Involvement of SUMOs in DNA repair was highlighted in experimentation using 
thymine DNA glycosylate (TDG). TDG is a DNA repair enzyme which removes uracil 
and thymine from U-G or T-G mismatched base pairs respectively, resulting in DNA 
devoid of a pyrimidine site (s) which is then repaired by downstream enzymes 
(Hardeland et al., 2002). 
In vitro studies with unmodified TDG show that the enzyme could only perform a single 
round of base removal as a result of being tightly bound to the reaction products 
(Johnson, 2004). Contrary to this, sumoylated TDG did perform multiple base removal 
reactions an indication that modified TDG was not being impeded by the end products 
(Johnson, 2004). 
2.5.4 Cell cycle regulation 
In addition to being involved in DNA repair, sub-cellular localization of proteins and 
modulation of transcription activity; SUMO modification has also been implicated in 
regulating progression of the cell cycle (Johnson et al., 1997). Saccharomyces cerevisiae 
SUMO- E1 and SUMO- E2 mutants have cell cycle defects and arrest at the G2 to M 
boundary (Johnson et al., 1997). Similarly, mutation of SUMO- E1 and SUMO- E2 in 
Schizosaccharomyces pombe resulted in cells with stern impaired growth and mitotic 
defects, leading to suggestions that SUMOylation is crucial for cell cycle progression 
(Hay, 2005).  
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2.5.5 A biotic stress response 
Saitoh et al., (2000) reported that in animals SUMO2/3 is involved in cellular response to 
environmental stress. Similarly SUMOs do indeed play an equivalent role in plant abiotic 
stress response. Exposure of Arabidopsis cells to ethanol and hydrogen peroxide (H2O2), 
caused a striking increase in SUMO conjugates while withdrawal of the two stress  
factors resulted in a reduction of SUMO conjugate levels (Kurepa et al., 2003). This 
observation could be an indication of involvement of SUMOs in plant stress response. 
2.5.6 Abscisic acid (ABA) signaling 
In addition to the aforementioned role in stress response, biological consequences of 
SUMOylation in plants extend to hormonal signaling in particular with the stress 
hormone ABA (Lois et al., 2003). Arabidopsis SUM1 over expressers have superior 
insensitivity towards ABA induced root growth inhibition (Lois et al., 2003). However, 
when SCE1 (sumo conjugating enzyme) activity is suppressed, the plants succumb to the 
ABA effect resulting in a stunted root growth phenotype (Lois et al., 2003). 
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CHAPTER THREE 
MATERIALS AND METHODS 

The study was conducted within the Department of Plant Physiology at Umea University 
(UmU). 
3.1    Construct 
The construct pRT104-GFP-RBR (7.2 kb) was used as the raw template for this study. It 
consisted of; vector pRT104, green fluorescent protein (GFP) and the full length RBR1 
protein from Arabidopsis thaliana.  
3.1.1 Mutation of SUMOylation site 
In order to generate RBR1 with a mutated SUMOylation site, nucleotides coding for the 
lysine at the SUMOylation site (KXE) in the wild type protein were substituted for 
alanine using Silent Site Selector web tool (http://rana.lbl.gov/SSS/). A forward and 
reverse primer pair was designed and synthesized to introduce the desired mutation by 
PCR- site directed mutagenesis 
3.2     PCR-site directed mutagenesis of SUMO conjugation site  
A 720bp RBR1 fragment denoted “RBR1-mtSUMO” with a mutated SUMOylation site 
was amplified by polymerase chain reaction using the primer pair; R:  5'-
ATAGGTACCCTATGAATCTGTTGGCTCGGTCGCGAGGGGTGCGGCACCAC-3' 
and F: 5'-TTCAGTCGACACATTGACCAGATCATTCTCTGTTGCTTCTACGGAGT 
GC-3'.  
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PCR amplification was performed in 200µL thermal tubes using a MJ mini thermo cycler 
(Bio-Rad, CA, USA), with each tube containing a 50µL reaction mixture containing; 
0.5µL of DNA template (15ng/µL) mixed with 2.5µL of each 0.5mM primer, 5µL of 10X 
PCR buffer (Invitrogen, Oxon, UK), 2.5µL of 2.5mM Invitrogen MgCl2, 1.25µL of 
0.25mM dNTPs, 0.75µL of Taq DNA polymerase (Invitrogen) and 35µL of water. The 
mixture was subjected to an amplification program with an initial denaturation step at 
95oC for 4 minutes followed by 30 cycles consisting of; annealing of primers with 
template at 55 oC for 1 minute, extension of primers at 72 oC for 1 minute and final 
elongation at 72 oC for 5 minutes. 
 
After PCR, 10µL of amplified product were resolved by gel electrophoresis on a 1% 
agarose gel containing 0.25µg/uL ethidium bromide while making use of a 1Kb DNA 
ladder (Invitrogen) to determine fragment size. After electrophoresis, fragment size was 
viewed using a UV documentation camera (Techtum Lab, Umea, Sweden).  
Next, 40uL of the remaining PCR product were treated with proteinase K (Fermentas, 
Vilnius, Lithuania) and purified by phenol/chloroform extraction (15:24:1, Sigma, 
Germany), precipitated, washed with 70% ethanol and finally resuspended in 15µL of 
water. Treatment with proteinase K was to remove tightly bound Taq polymerase that 
would interfere with restriction digestion. 
3.3      Cloning RBR-mtSUMO 
The construct pRT104-GFP-RBR was double digested with appropriate restriction 
enzymes to rid it of the C-terminal part of RBR1 protein which was subsequently 
replaced with amplified RBR1 containing a mutated SUMOylation site. 

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3.3.1    Restriction and ligation 
3µg of the cloning vector were digested with enzyme SalI (Fermentas) for 2hrs at 37˚C 
after which enzyme activity was terminated with 65˚C incubation on a heating block. 
After 15 minutes the vector was purified by phenol/chloroform extraction, precipitated, 
washed with 70% ethanol and finally resuspended in 15µL of water. It was re-digested 
with KpnI (Fermentas) for 2hrs at 37˚C after which enzyme activity was terminated by 
incubating at 80˚C on a heating block.  
Next, the vector was dephosrylated in a reaction containing; 25µL of vector, 2.9µL 10X 
dephosphorylation buffer and 1µL of shrimp alkaline phosphate (Fermentas). The 
reaction was performed at 37˚C for 30minutes followed by termination of SAP activity at 
70˚C for 15 minutes. The DNA was resolved on a 1% agarose gel and isolated using the 
NA45 membrane (Schleicher and Schuell Bioscience, Dassel, Germany). 
 
Prior to ligation, restriction of the PCR product was done with the same enzymes and 
conditions used for the vector. The vector and insert were then ligated together in a 10uL 
reaction; 5uL of insert, 3uL of vector, 1uL 5X ligase buffer and 1uL T4DNA ligase 
(Invitrogen). Ligation was done over night at 12˚C in a thermo cycler (Bio-Rad). 
3.3.1.1    Transformation of Escherichia coli 
100µL of thawed XLI blue E.coli competent cells in a 1.5mL Eppendorftube were mixed 
with 10µL of ligation mix and left on ice, after 30 minutes the cells were heat shocked in 
a water bath at 42˚C for 90 seconds. 900uL of SOC medium (5X SOB media, glucose 
and water) were immediately added to the heat shocked cells to aid cell recovery. Next, 
the transformed cells were placed on a rotary shaker at 37˚C for 1hour after which 200µL 
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of the cells were spread on LB plates and grown overnight at 37˚C. From the overnight 
LB plates, a single colony was used to inoculate 5ml of LB media (containing 50mg/L 
carbenicillin) in a 15mL falcon tube overnight at 37˚C. 
Mini-preparation was performed using a QIAprep spin mini-prep kit (Qiagen, Solna, 
Sweden) following the manufacturer’s guidelines. To detect presence of the mutation, 
mini-preps were double digested in a single reaction with SalI and NruI (Fermentas). The 
NruI restriction site had been integrated into the reverse primer used to induce the 
mutation. Furthermore, the minipreps were sequenced using a 35S terminal antisense and 
a pRT104 35S primer.  
3.4     Transient expression of GFP-RBRmtSUMO in suspension culture cells 
3.4.1   Transfection of protoplasts 
 
4 day old Arabidopsis thaliana root suspension cells were collected in a 50mL falcon 
tube by centrifugation at 1200rpm, 5 minutes in a ZK380 centrifuge (Hermle, Wehingen, 
Germany), after which the supernatant was discarded. In order to rid the cells of their cell 
walls, they were resuspended in 25mL of enzyme solution which was topped up with 
25mL of B5-0.34M glucose mannitol (Table 1). Re-suspended cells were then transferred 
to petri-dishes and subjected to vigorous shaking on a rotary shaker. 
After 4hrs, the cell suspension was centrifuged, supernatant discarded and the pellet 
resuspended in 25mL of B5-0.34M glucose mannitol followed by further centrifugation. 
Viable cells were collected by re-suspension in 5mL of B5-0.28M sucrose in which they 
floated. 
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Table 1: Composition of solutions used in transfection of Arabidopsis protoplasts. 

Prior to transformation of protoplasts, a single positively sequenced colony was used to 
inoculate 2mL of fresh LB medium for a scale up culture. After 2.5hrs, 2mL of scale up 
culture were added to 50mL of fresh LB medium (100µg/mL carbenicillin) and grown 
overnight at 37˚C with shaking. Plasmid DNA was prepared using a plasmid mid kit 
(Qiagen) as described by manufacturer. 
3-5g of plasmid DNA (GFP-RBRmtSUMO) were gently mixed with 50µL of 
protoplasts followed by 150µL of PEG solution, the transformation mix was left in the 
dark at room temperature for 30 minutes. Protoplasts were twice washed with 0.275M 
Ca(NO3)2 to clear them of PEG solution after which they were collected by centrifugation 
and mixed with 0.5mL of B5-0.34M glucose mannitol. The cells were placed in a 
microtiter plate and incubated overnight in the dark; localization of GFP in the 
transfected cells was performed by confocal laser scanning microscopy 
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3.5      Sub cloning RBR-mtSUMO into vector pGEX-5X-1  
Fragment RBR-mtSUMO was digested with SalI (Fermentas) while expression vector 
pGEX-5X-1 was first digested with XhoI (Fermentas), next the ends were filled with 
Klenow polymerase (Takara, Saint-Germain-en-Laye, France) to clear the vector of 
protruding 3' overhangs produced by XhoI. The Klenow filling reaction contained 20uL 
of vector, 3uL 10X Klenow buffer, 0.5µL 2.5mM dNTP, 0.5µL Klenow polymerase and 
26uL of water. The mixture was incubated at room temperature for 10 minutes followed 
by incubation at 70˚C on a heating block to terminate Klenow activity. 
Next the vector was digested with SalI, dephosphorylated with shrimp alkaline phosphate 
and purified from a 0.8% agarose gel using the NA45 membrane (Schleicher and 
Schuell). The purified vector was ligated with the insert (RBR-mtSUMO) after which the 
ligation was used to transform E. coli XL1blue competent cells. 
 
Mini-preparation was done using a QIAprep spin mini-prep kit (Qiagen). To verify 
presence of the insert, mini-preps were digested with NruI (Fermentas), SalI (Fermentas) 
and resolved by electrophoresis on a 0.8% agarose gel. Positive mini-prep samples were 
further sequenced with the sequencing primers GEX lower (5'-CCGGGAGCTGCATGG 
TCAGAGG-3') and GEX upper (5'-GGGCTGGCAAGCCACGTTTGGTG-3').  
3.6 Protein Expression and purification 
3.6.1 Expression of RBR-mtSUMO 

0.5uL of mini-prep DNA (pGEX-5X-1-RBR-mtSUMO) were used to transform 100uL of 
E.coli BL21 cells by heat shock, the cells were spread on LB plates containing 
Carbenicillin (100µg/mL) and grown overnight at 37˚C. A single colony was used to 
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inoculate 5ml of LB medium (100µg/mL carbenicillin) overnight at 37˚C. Next, a scale 
up culture containing 3mL of overnight culture and 200ml fresh LB medium was grown 
without induction. 
After 2.5hrs, 200mL of scale up culture were added to 600mL of fresh LB medium 
(100µg/mL carbenicillin); the overall culture was grown at 37˚C until its OD600 reached 
0.7. 80uL of isopropyl-b-D-1-thiogalactopyranoside (IPTG) were then added to the 
culture to a final concentration of 0.1mM after which growth was continued at 28˚C for 
2.5hrs. The cells were eventually harvested by centrifugation at 3000g for 20minutes in a 
J-20xp centrifuge (Beckman coulter, CA, USA); the resulting pellet was retained while 
the supernatant was discarded. 
3.6.2 Purification  
Each gram of pelleted cells was re-suspended in 5mL of lysis buffer (25mM Tris-HCl 
pH7.8, 100mM NaCl, 2mM EDTA, 1mM DDT, 0.5mM PMSF and 1mM Benzamidin) 
followed by 0.5mg/mL of lysozyme and 0.2% Triton X-100 with gentle stirring at 4˚C. 
The cell suspension was agitated for 12 minutes with a Branson sonifier (Kebo Lab, 
Sweden), before adding 0.1mg/mL of DNase and MgCl2 to a final concentration of 
10mM.  
Next the cell lysate was centrifuged at 12000g for 30 minutes; the resulting supernatant 
was filtered through a 0.45 cartridge (Sarstedt,Nümbrecht, Germany) after which 5M 
NaCl was added to the filtrate culminating in a final salt concentration of 200mM. In 
order to bind the protein, 0.5mL of Glutathione-Sepharose resin equilibritaed in lysis 
buffer were next added to the filtrate with gentle stirring at 4˚C.  
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After 45 minutes the resin solution was thrice washed with lysis buffer, 10 protein 
fractions were then eluted  each with 1mL of 10X elution buffer ( 50mM Tris-HCl pH8.0, 
200mM NaCl, 1mM DDT, 0.02% Triton X-100 and 10mM reduced glutathione). The 
protein fractions were left in dialysis buffer (25mMTris-HCl ph 7.8, 100mM NaCl, 1mM 
EDTA, 1mM DDT, 10% glycerol, 0.2mM PMSF and 0.5mM Benzamidine) overnight at 
4˚C. After dialysis proteins were concentrated using micron YM-30 filters (Millipore), 
protein concentration was measured and aliquots were flash frozen in liquid Nitrogen 
before storage at -80˚C for later use. 
3.6.3 Electrophoresis of protein fractions 
SDS-polyacrylamide gel electrophoresis was performed at 20Amps in a glass encased  
gel consisting of a 10% resolving gel (30% Acrylamide/bisacrylamide mix, 1.5M Tris 
pH8.8, 10% SDS, 10% Ammonium persulfate, Temed and water) and a 1.5 cm stacking 
gel (30% Acrylamide/bisacrylamide mix, 1M Tris pH6.8, 10% SDS, 10% Ammonium 
persulfate, Temed and water). To 16µL of each protein fraction, 5X SDS loading buffer 
(250mM Tris-HCl pH6.8, 10% SDS, 30% Glycerol, 5% -mercaptoethanol, & 0.02% 
bromophenol blue) was added. The samples were boiled at 95˚C for 5 minutes and loaded 
for electrophoresis together with a Dalton VIIL molecular marker (Sigma). 
After electrophoresis, the gel was incubated in coomassie brilliant blue (CBB) for 30 
minutes. It was then repeatedly washed with destaining buffer (20% methanol and 7% 
acetic acid) until the protein bands were clearly visible. 
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3.7 In-vitro SUMOylation 
The in-vitro assay was performed using a SUMOylation kit (Enzo, NY, USA). Four 
separate reactions were set up in 1.5mL Eppendorf tubes as shown in table 2. The 
reaction tubes were then incubated on a heating block at 30˚C, after 1hr the reaction was 
stopped by adding 60µL of stop buffer (1X PBS, 25mMEDTA and 0.2mg/mL BSA) to 
each tube. 10µL of GST-magnetic beads were then added to each tube to bind the 
proteins, the reaction was conducted at 4˚C with gentle shaking. Next the magnetic beads 
in each tube were thrice washed with 150µL of wash buffer (1X PBS and 0.1mg/mL 
BSA) followed by protein elution with 35µL of 1X SDS sample buffer. The samples 
were boiled for 5 minutes at 95˚C. 
Table 2: Composition of reactions used for the in-vitro SUMOylation assay 

3.7.1 Electrophoresis and western blot analysis 
SDS-polyacrylamide gel electrophoresis was performed in a glass encased gel consisting 
of an 8% resolving gel and a 1.5 cm stacking gel.  15uL of each sample were loaded into 
the gel wells together with 5uL of protein molecular marker (All blue). 
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After electrophoresis, proteins were electrophoretically transferred to a 6.5 by 9 cm 
PVDF membrane (Millipore, MA, USA) in transfer buffer (50mM Trisbase and 50mM 
Boric acid) overnight at 4˚C in a trans-blot apparatus (Bio-Rad).  
Subsequent to overnight protein transfer, the PVDF membrane was stained with Ponceau 
S solution for 1 minute to detect protein bands after which it was destained using 1% 
acetic acid. Next the membrane was incubated in blocking solution at room temperature, 
after 2hrs it was rinsed with 1X TBST (50mM Tris-pH8.0, 150mM NaCl and 0.05% 
Tween) and re-incubated in 4mL of blocking solution containing an anti-RBR antibody 
for 2hrs. This was followed by re-incubation with a peroxidase-conjugated rabbit anti-
chicken (IgG) for 1hr. 
After antibody incubation, the membrane was washed with 25mL of TBST; 25mL 
blocking solution diluted with TBST, 25mL of TBST and lastly with Milli-Q water each 
wash lasting 10 minutes. Finally, the immunoreactions present on the PVDF membrane 
were developed onto x-ray film using enhanced chemiluminescence (ECL, Bio-Rad). 
 
 


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CHAPTER FOUR 
RESULTS 
4.1 Mutation of Arabidopsis RBR1 SUMO modification site  
Modification by SUMO occurs at the KXE sequence motif which is present in almost 
all substrate proteins. The motif is made up of a large hydrophobic amino acid (), a 
Lysine (K) which is modified, an amino acid residue (X) and a glutamic acid denoted E 
(Johnson, 2006). Hence in order to study the effect of SUMOylation on the 
Retinoblastoma related protein (RBR1), a mutation was introduced in the nucleotides 
coding for the Lysine amino acid at the SUMOylation site. 
Alignment of C-terminal sequences (Fig. 3a) of RBR proteins from different plants 
shows the presence of the SUMOylation motif (KXE). The Arabidopsis RBR1 protein 
carrying a mutation at the SUMOylation site was amplified by PCR-site directed 
mutagenesis resulting in a 720bp fragment (Fig. 3b, Lane 2).  
 
Figure 3 (a) Alignment of C-terminal sequences of different plant RBR proteins showing 
the presence of a SUMOylation motif (KXE). (b) 720bp RBR1 fragment (Lane 2) with 
a mutated SUMOylation site amplified by PCR, in lane 1 is the 1Kb DNA ladder. 
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4.2 Effect of SUMO modification on RBR1 localization 
In order to assess the effect of SUMO modification on RBR1 localization, Arabidopsis 
protoplasts were transfected with plasmid DNA coding for wild type RBR1 and RBR1 
carrying a mutated SUMOylation site. Both constructs contained the green fluorescent 
protein to aid in protein localization.  
In protoplasts transfected with wild type DNA, the protein was exclusively localized in 
the nucleus (Fig.4; a-c). However, protoplasts transfected with the protein carrying a 
mutated SUMOylation site, localization was not exclusive to the nucleus but also in the 
cytosol (Fig.4; d-f). 

Figure 4 Effect of SUMO on RBR1 localization in Arabidopsis protoplasts, 14hrs after 
transformation. (a-c) In protoplasts transformed with the wild type protein (wtRBR1-
GFP), the green fluorescent protein is exclusively localized in the nucleus. (d-f) 
Transformants with RBR1-mtSUMO containing a mutated SUMOylation site however 
show that the GFP is not exclusive to the nucleus but also in the cytosol. 
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4.3 Expression and Purification of protein RBR1-mtSUMO 
To assess the effect of mutating Lysine 1007 on RBR1 SUMOylation, the amplified PCR 
product (RBR1-mtSUMO) carrying a mutated SUMO modification site was sub cloned 
into a glutathione-s-transferase (GST) gene fusion vector (pGEX5X-1) for protein 
expression. Cell pellets were obtained from LB media before and after induction of 
protein expression. After induction of protein expression with IPTG, RBR1-mtSUMO 
(52KDa) was clearly expressed (Figure 5a, Lanes 3 and 5). The protein was subsequently 
purified using glutathione Sepharose resins (Figure 5b, Lanes 3 and 4). 
 
Figure 5 Protein expression and purification. (a) Expression of the protein RBR-
mtSUMO; Lanes 2 and 4 are from samples before induction of protein expression while 
lanes 3 and 5 are samples taken after induction showing the expressed protein ~52KDa. 
(b) Protein purification; Lanes 3 and 4 show the purified protein. In both figures, lane 1 
contains the molecular weight marker. 
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4.4 Mutation of Lysine 1007 prevents modification of RBR1 by SUMO 
The purified protein was tested using an in vitro SUMOylation assay kit to determine if it 
could be modified by SUMO. The assay contained RBR1-mtSUMO or RBR1-wt, SUMO 
precursor, E1 enzyme, E2 enzyme and Mg-ATP. Figure 6a, shows protein transfer on to 
the PVDF membrane after staining in Ponceau S solution for 1 minute. When the wild 
type protein was incubated with all the components of the SUMOylation assay (Fig 6b, 
Lane 2), a SUMO modified protein was observed slightly less than 75KDa. On the 
contrary, the wild type protein which was incubated in the assay lacking the E1-activating 
and E2-conjugating enzymes was not modified (Figure 6b, Lane 1). Even in the presence 
of all assay components, the protein carrying a mutated site could not be SUMOylated 
(Figure 6b, Lane 4). The same result was observed when the mutated protein was 
incubated in the assay lacking the activating and conjugating enzymes (Figure 6b, Lane 
3). 
 
Figure 6 Ponceau staining and in-vitro SUMOylation. (a) Ponceau staining of the PVDF 
membrane showing protein transfers (b) In-vitro SUMOylation; Lane 1 contained the 
wild type protein (wt-RBR1) in the absence of the E1 and E2 enzymes. Lane 2 had the 
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wild type protein in the presence of all assay components; the protein was subsequently 
modified to yield the protein (GST-RBR-Ct-SUMO).  Lane 3 contained the mutated 
protein negative control lacking E1 and E2 enzymes while Lane 4 had the mutated 
protein with all assay components.  
 
 
Both the negative and positive controls (Figure 6b, Lanes 3 and 4) of the protein carrying 
a mutation were not SUMOylated, implying that the mutation prevented modification. 
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CHAPTER FIVE 
DISCUSSION 
5.1 Discussion 
Before 1997, ubiquitin was perhaps the most known polypeptide to be involved in post 
translational modification of proteins (Marx, 2005). However a number of other 
polypeptides have since been indentified SUMO being among them (Kurepa et al., 2002). 
Substrate proteins contain a characteristic KXE sequence motif specific for 
SUMOylation; mutation of the lysine within the motif has been shown to affect 
modification and localization of RanGAP1 a nuclear transport protein in animals 
(Matunis et al., 1998). 
Alignment of the Arabidopsis retinoblastoma related protein (RBR1) sequence with other 
plant sequences, revealed the presence of the unique SUMOylation motif in all 
sequences. Hence in this study Lysine 1007 located within the motif was mutated in order 
to address the effect of SUMO modification on RBR1. The outcome of the mutation was 
highlighted by restricted localization of the wild type protein in the protoplast nucleus 
while the protein carrying a mutation was seen to be present in both the cytosol and the 
nucleus. 
Johnson (2004) noted that in addition to sub cellular localization of proteins, modification 
by SUMO alters protein to protein interaction and protein interaction with other 
substrates. Hence localization of the wild type protein in the nucleus observed in this 
study could most likely be a post SUMO modification effect caused by; interactions 
between SUMO (the modifier) and nuclear proteins resulting in sub cellular localization 
of the modified wild type protein. 
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Additionally as noted by Gill (2005), modification of transcription factors by SUMO 
enhances their interactions with proteins that would normally have less or no interaction 
with the unmodified protein. Hence there is still a likely possibility that after modification 
of RBR1, there is an onset of interactions between the modified protein and nuclear 
proteins resulting in the eventual sub-cellular localization of the protein. 
Alternatively it is also possible that once sumoylated, the wild type protein undergoes 
conformation changes that could expose or conceal certain binding sites. These changes 
in protein conformation could play a major role in facilitating eventual localization of the 
protein in the nucleus. Unlike the wild type protein, the absence of these SUMO induced 
effects on the mutated protein could be the cause of its presence in the cytosol.  
 
It is however important to highlight the fact that, a fatal error was noticed during the 
course of the study. The delivered forward primer which was used for site directed 
mutagenesis deviated from the native sequence as it contained a point mutation in form of 
a missing T nucleotide. Putting that in consideration it is likely that the construct GFP-
RBR1-mtSUMO had an additional mutation instead of the required one at the 
modification site. This without doubt results in a truncated protein, unable to be 
sumoylated and hence ending up in the cytosol giving the impression that it’s the 
unmodified full length protein.  
 
Having rectified the primer problem prior to protein expression, the results from the in 
vitro SUMOylation assay did clearly show that the wild type protein was SUMOylated. 
However in the absence of an acceptor lysine, the protein RBR1-mtSUMO could not be 
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SUMOylated. This result is similar and in agreement with results obtained from a related 
study by Matunis et al., (1998) where they showed that, substituting the acceptor lysine 
for arginine in RanGAP1 prevented modification of the protein by SUMO. 
5.2 Conclusions 
In conclusion, transfection results from this study do not provide undisputed confirmation 
that modification by SUMO affects sub-cellular localization of RBR1. However, the in-
vitro study did certainly confirm that, the plant retinoblastoma-related protein can’t be 
modified by SUMO in the absence of the acceptor lysine contained in its modification 
site. 
Additionally it can also be concluded that failure of the mutated protein to undergo 
modification, means that the C-terminal of RBR1 contains a single SUMOylation site. 
5.3 Future Direction 
Though protein localization seen in this study is in agreement with results from related 
mutational studies, the first course of action would be to re-transform protoplasts with a 
corrected construct in order to confirm that the mutated protein is indeed localized in both 
the nucleus and the cytosol unlike the wild type protein. 
In order to confirm the presence of the transiently expressed GFP-tagged protein, it can 
be extracted from the transfected cells and subjected to immuno blot analysis with GFP 
and RBR1 specific antibodies.  
It would also be interesting to do a structural study to get a clear picture of the structures 
of the wild type protein, its SUMO modified form and the mutated protein using studies 
such as nuclear magnetic resonance (NMR) or X-ray crystallography. This would shade 
more light on the occurrence of SUMO induced conformational changes. 
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